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Abstract
Background: The rise of Multidrug-resistant organisms (MDROs) poses a considerable burden on the healthcare
systems, particularly in low-middle income countries like Pakistan. There is a scarcity of data on the carriage of
MDRO particularly in the pediatrics population therefore, we aimed to determine MDRO carriage in pediatric
patients at the time of admission to a tertiary care hospital in Karachi, Pakistan, and to identify the risk factors
associated with it.
Methods: A cross-sectional study conducted at the pediatric department of Aga Khan University Hospital (AKUH)
from May to September 2019 on 347 children aged 1–18 years. For identification of MDRO (i.e., Extended Spectrum
Beta-Lactamase (ESBL) producers, Carbapenem Resistant Enterobacteriaceae (CRE), Vancomycin Resistant Enterococci
(VRE), Methicillin Resistant Staphylococcus aureus (MRSA), Multidrug-resistant (MDR) Acinetobacter species and MDR
Pseudomonas aeruginosa), nasal swabs and rectal swabs or stool samples were cultured on specific media within 72
h of hospitalization. Data was collected on a predesigned structured questionnaire on demographics, prior use of
antibiotics for > 48 h in the last 6 months, history of vaccination in last 6 months, exposure to health care facility
regardless of the time of exposure, ICU stay for > 72 h, and about the prior use of medical devices (urinary catheter,
central venous lines etc.) in last 1 year. Statistical analysis was performed by Standard statistical software.
Results: Out of 347 participants, 237 (68.3%) were found to be MDRO carriers. Forty nine nasal swabs from 346
children (14.2%) showed growth of MRSA. The majority of the stool/rectal swabs (n = 222 of 322; 69%) collected
were positive for MDRO. The most isolated species were ESBL Escherichia coli 174/222 (78.3%) followed by ESBL
Enterobacter species 37/222 (16.7%) and ESBL Klebsiella pneumoniae 35/222 (15.8%). On univariate analysis, none of
the risk factors showed statistically significant association with MDRO carriage.
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Conclusion: Overall, a high prevalence of MDRO carriage was identified among admitted pediatric patients.
Implementation of systematic screening may help to identify true burden of MDROs carriage in the health care
settings.
Keywords: Multidrug-resistant organisms, Carriage, Prevalence, Pediatric patients
Background
The rapidly emerging multidrug-resistant organisms
(MDROs) associated infections with meager and
scarce availability of better therapeutic options are
among the prioritized global health concerns [1].
Based on drug resistance patterns, MDROs are cate-
gorized into multidrug-resistant (MDR), extensively
drug-resistant (XDR) and pan drug-resistant (PDR)
pathogenic bacteria.” MDROs are non-susceptible to
at least one agent in three or more antimicrobial cat-
egories, XDR bacteria are non-susceptible to at least
one agent in all but two or fewer antimicrobial cat-
egories, and PDR bacteria are non-susceptible to all
agents in all antimicrobial categories [2].
The spectrum of hospital acquired multidrug bacteria
include Staphylococcus aureus, Enterococci species,
members of family Enterobacteriaceae, Pseudomonas
aeruginosa, and Acinetobacter species [3]. Although the
prevalence of these pathogens varies geographically,
temporally and by healthcare settings, no institution is
without the menace from these organisms rendering
the standard of public health in many regions of the
world equivalent to the pre-antibiotic era [4]. Besides
heightening the risk of morbidity and mortality in vul-
nerable individuals, other negative repercussions of
MDROs include longer hospitalization and higher med-
ical costs [5, 6].
Over the past two decades, the strains of MDROs have
quadrupled particularly among children and cause ser-
ious bacterial infections (SBIs) including bacteremia,
meningitis, bone and joint infections, urinary tract infec-
tions (UTI), gastroenteritis, and skin or soft tissue infec-
tions [7, 8]. National Healthcare Safety Network
(NHSN) reported that MDROs cause infections in ̴ 5–
10% hospitalized children [9]. Studies reported a 4%
annual increase in multidrug resistant strains of P. aeru-
ginosa [10] and a significant rise in carbapenem resist-
ance in Enterobacteriaceae strains [11, 12]. The cases of
vancomycin resistant enterococci infections in hospital-
ized children also increased from 53 per million in 1997
to 120 per million in 2012.
Acquisition of these drug resistant bacteria in infants
is either through the mother or from the community
[13]. A Report from a tertiary care hospital of Tunisia
showed 8.9% of their pediatric patients’ colonization
with at least one drug resistant bacteria before and dur-
ing hospital admission [14]. In the USA approximately
4% of children admitted to a Pediatric Intensive Care
Unit (PICU) were found to be carriers of MDR Entero-
bacteriaceae [15]. Colonization of MDR Streptococcus
pneumoniae was reported 5% among healthy Thai chil-
dren [16].
The colonization locations include body sites normally
inhabited by indigenous human microbiota or in chronic
wounds, renal calculi, devitalized bones, and indwelling
foreign bodies [3]. Left unchecked, these carriers serve
as reservoirs and vehicles in the transmission of
MDROs; raise the burden of MDRO infections in health
care particularly in intensive and acute care settings [17].
There are multiple ways to detect the MDRO carriers
like from rectal and nasal swabs. It has been shown that
the sensitivity of detecting microorganisms like MRSA
can be increased by taking cultures from multiple sites
like the nose, pharynx, and skin instead of just one site.
Moreover, using skin sponges instead of skin swabs can
also increase the detection sensitivity by covering a lar-
ger skin area [18].
There are studies regarding MDROs associated infec-
tions in Pakistani adults [19–22], but relatively scarce
data is available of the pediatric population. Moreover,
the focus of previous studies was on the acquisition of
MDROs during hospital stay rather than identification of
MDRO carriage at the time of admission [23]. We hy-
pothesized that there is an association between MDRO
carriage and risk factors such as prior use of antibiotic,
prior hospitalization, or exposure to health care facility
in children. Therefore, the objective of our study is to
determine the prevalence of carriage of specific MDROs
in pediatric patients admitted to a tertiary care center in
Karachi and the risk factors associated with the carriage.
This data will help to propose and develop guidelines for
appropriate selection and usage of antibiotics and will
impact infection control practices and antimicrobial
stewardship efforts.
Methods
Patients and Study setting
We conducted a cross-sectional study including all
pediatric patients aged 1–18 years admitted to the
pediatric ward at the Aga Khan University Hospital
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(AKUH), Pakistan, from May to September 2019. Partic-
ipants were screened for identification of MDRO carriers
including MRSA, VRE, CRE and ESBL-producing gram
negative bacteria within 72 h of admittance. Patients
with a documented history of culture proven MDRO in-
fection or carriage during the previous 12months of ad-
mission, diagnosed cases of primary or secondary
immunodeficiency, and those who refused to participate
in the study were excluded.
This study was approved by the Ethical Review Com-
mittee (ERC) of AKUH (2019–0653-2209). All methods
including enrolment of patients, data collection, micro-
biological and statistical analysis were in accordance
with the guidelines and regulations of institutional ERC.
The sample size was calculated by OpenEpi. Assuming a
rate of MDRO carriers in the general population as 30%,
5% bound on the error, 5% significance level, the max-
imum sample size was 323. Sample size was also calcu-
lated for associated risk factors such as prior use of
antibiotics, prior hospitalization, ICU stay etc. by taking
frequency of these factors among non-MDRO carriers
between 30% and 50%, 80% power, 5% significance level,
and ratio of-MDRO carriers to non-MDRO carriers as 1:
2, with a prevalence ratio (PR) of 2.00 and 5% attrition,
the sample size estimated was at least 323.
Data collection method
Data was collected aftertaking consent from parents or
guardians of patients, on demographics, prior use of an-
tibiotics for > 48 h in the last 6 months, history of vac-
cination in last 6 months, exposure to health care facility
regardless of the time of exposure, ICU stay for more
than 72 h, and about the prior use of medical devices
(urinary catheter, central venous lines etc.) in last 1 year.
We cultured the nasal swab for MRSA, and either rectal
swab or stool specimen for ESBL Enterobacteriaceae,
carbapenem resistant Enterobacteriaceae, vancomycin
resistant enterococci, MDR Acinetobacter species, and
MDR P. aeruginosa within 72 h of hospitalization for the
detection of these pathogens. Patient was identified as
MDRO carrier if a (nasal, rectal or stool) was positive,
and the patient was without systemic infection caused
by these organisms.
Microbiological analysis
For the detection of VRE, rectal swabs/stool specimens
were streaked directly onto selective agar plates and in-
cubated aerobically for 24 h. Isolated colonies of entero-
cocci were confirmed as E. faecalis or E. faecium by
biochemical test and API strep kit test. These isolates
were confirmed as vancomycin resistant by vancomycin
disc on SB-Mueller-Hinton agar (SBMHA) plate and iso-
lated on 6mcg/ml vancomycin plate with negative and
positive control.
Swabs were also inoculated into a broth medium con-
taining 6 mcg/ml vancomycin (Enterococcosel). Broth
with color change from amber to black after 24–48 h in-
cubation at 37 °C was then sub-cultured on blood agar
and selective VRE media and incubated overnight at
37 °C. For further confirmation of isolated colonies API
strep kit test and vancomycin disc on Mueller Hinton
Agar (MHA) media was performed.
For identification of MRSA, nasal swabs plated directly
onto sheep blood agar (SBA) and mannitol salt agar
(MSA) and incubated aerobically for 24 h in a CO2 incu-
bator. A Swab was also inoculated into 2.5% NaCl BHI
(Brain Heart Infusion) broth and after incubation at
37 °C for 24 h; it is inoculated onto colistin nalidixic acid
agar (CNA), MSA, and SBA plates. The plates were in-
cubated at 37 °C for 24 h. Morphologically resembling S.
aureus was confirmed by tube coagulase (for secreted
extracellular coagulase), DNase agar, and phenolphthal-
ein phosphate agar. Broth or saline suspension of col-
onies confirmed as S. aureus was prepared and adjusted
to achieve turbidity of 0.5 McFarland standards. Sensitiv-
ity testing carried out by disc diffusion method against
cefoxitin 30 mcg disc susceptibility breakpoints for
cefoxitin against S. aureus and was interpreted using
Clinical and Laboratory Standards Institute (CLSI)
guidelines.
Rectal swabs and stool specimens were inoculated
into BHI broth and after overnight incubation at 35 ±
2 °C with ambient air, vortexed, and subcultured 100 μl
onto MacConkey and CNA agar plate with vancomycin
disc placed on 1st streak of CNA. Followed by over-
night incubation, all gram negative bacilli were identi-
fied by conventional biochemical identification method
that includes oxidase test, triple sugar iron (TSI) agar,
Sulphide indole motility (SIM) agar, citrate agar, urea
agar, Pseudomonas agar P, and Pseudomonas agar F.
Identification of ESBL producing Enterobacteriaceae
was performed by disc diffusion method by using com-
bination of clavulanic acid (10 μg) and ceftazidime
(30 μg). Both discs were placed on Muller Hinton agar
plates which were earlier swabbed by respective culture
and incubated for 24 h at 37 °C. More than 5 mm in-
crease in the zone diameter for ceftazidime-clavulanic
acid was considered positive ESBL production. Pheno-
typic disc diffusion method with Imipenem disc (10 μg)
on Muller Hinton agar plates and incubated for 24 h at
37 °C were used for detection of carbapenem resistance
in Enterobacteriaceae (zone size ≤19 mm), Acinetobac-
ter species (zone size ≤18 mm), and P. aeruginosa (Zone
size ≤15 mm). Identification of XDR S. Typhi was done
using conventional biochemical methods i.e., TSI, SIM
agar, and confirmed with the help of serotyping (BD
Difco Salmonella O Antiserum Factor 9) and API 20E
(Biomerieux).
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Statistical analysis
Statistical analysis was performed on Stata version
12.0. Descriptive statistics were reported as frequen-
cies with percentages for categorical variables like
gender, prior use of antibiotics, prior hospitalization,
etc., and mean ± SD was reported for age (years). Uni-
variate analysis was performed by Cox proportional
hazards algorithm, p-value ≤0.25 was considered sig-
nificant. The results are reported as crude PR with
95% confidence intervals.
Results
A total of 1509 patients were admitted during the study
period and screened for participation, of which 528
(35%) fulfilled the eligibility criteria. 350 (66.3%) con-
sented to participate and were enrolled (Fig. 1). Three
patients were excluded from the analysis as they refused
to provide samples. The details of demographic and clin-
ical characteristics are provided in Table 1. The com-
mon underlying diagnosis of the participants were 48.7%
infections followed by 17.3% gastrointestinal and 12.7%
respiratory illnesses (Table 2). From 322 stool/rectal
swab specimens collected, 222 (68.9%) were positive for
MDRO. The most isolated species were ESBL E. coli
174/222 (78.3%) followed by ESBL Enterobacter species
37/222 (16.7%) and ESBL K. pneumoniae 35/222 (15.8%)
(Fig. 2). None of the risk factors was statistically signifi-
cant on univariate analysis (Table 3).
Discussion
In this study, we did a systematic screening of Pakistani
children to assess MDRO carriage amongst them. The
overall MDRO carriage in our study was found to be
very high i.e. 68.3% as compared to China where overall
MDRO prevalence is 36% [24]. The proportion of MRSA
carriage was also elevated (14.2%) in contrast to China
where MRSA carriage is 6.4% (28). Out of 322 stool/rec-
tal swab specimens, 68.9% were positive for MDRO. The
most isolated species were ESBL E. coli (78.3%), ESBL
enterobacter species (16.7%), and ESBL K. pneumoniae
(15.8%). These observed percentages were also higher
than those previously reported from other countries
such as Guinea-Bissau (ESBL E. coli 47.7% and K. pneu-
moniae 15.8%), Madagascar (ESBL E. coli and K. pneu-
moniae 36.9%), Lebanon (ESBL Enterobacteriaceae
24.9%), and Thailand (ESBL E. coli 67.5% and K. pneu-
moniae 19.4%) [25–28].
The risk factors reportedly associated with MDRO car-
riage include age, increased usage of antibiotics [29],
prior exposure to hospital settings; especially to the ICU
[14] and the total length of stay in hospital settings [30].
In our study, none of these risk factors was found to be
associated with MDRO carrier. One study reported that
the use of cephalosporin within the preceding 4 months,
age less than 2 years, and having a sibling colonized with
resistant Streptococcus pneumoniae (S. pneumoniae)
were significantly associated with carriage of resistant S.
pneumoniae [31]. Another study showed no association
Fig. 1 Study flow (Uploaded as a separate PDF file)
Qureshi et al. BMC Infectious Diseases          (2021) 21:547 Page 4 of 9
of MDRO carriage with age and gender but a significant
association of MDRO carriage with use of antibiotics in
the last 30 days, hospitalization in the past 2 years, and
intrahospital transfer [32]. On the contrary, findings re-
ported from Thailand were less conclusive and did not
find any significant association of MDRO carriage with
antibiotic use in the past 30 days [16]. Similarly, there
are further studies that were inconclusive for any associ-
ation of MDRO carriage with age, gender, previous anti-
biotic use, or hospitalization [14, 32].
Poor hygiene and sanitary conditions likely contribute
as a factor for the high percentage of MDRO carrier in
our region. Our findings also raise the concern of
asymptomatic carriage of MDRO in the community.
This increases the risk of dissemination of resistance
genes by human-to-human transmission or by contam-
ination of the environment [33]. Although, antibiotic
history was not found to be significantly associated with
MDRO carriage in our study, however, literature men-
tions it as a factor significantly associated with increased
rates of MDROs in the community, including young in-
fants [34]. Other risk factors contributing to the high
percentage of MDRO carriage include self-prescription
and inappropriate usage of antibiotics [35, 36], nescience
and lack of effective antimicrobial stewardship programs
in hospitals [37] and scarcity of physicians specialized in
pediatric or adult infectious diseases [38]. Our results
might increase the awareness among physicians about
the high prevalence of MDROs in the pediatric age
group and young infants. It might also encourage all
healthcare providers to contribute stopping the spread
of MDRO by using the appropriate antibiotics in the in-
patient and outpatient settings.
Our study is not free of limitations. The current data
from a single-center study may not reflect the prevalence
of MDRO in Pakistan as a whole. Therefore, a multicen-
ter study is needed to compare different healthcare facil-
ities across urban and rural settings of our region to get
a better understanding of the situation. As this study
was observational, there might be a recall bias which
may explain the lack of a significant association between
prior antibiotic use and MDRO carriage. Furthermore,
the narrow time frame of this study restricted how much
the effect of climatic conditions on MDRO carriage
could be researched.
Regardless of all these limitations, the current study is
of great importance as to the best of our knowledge it is
the first study of our region that presents data on
MDRO carriage in pediatric patients.
Conclusion
High prevalence of MDRO carriers in children poses a
great public health concern, especially in developing
countries like Pakistan where the health care system is
already over-burdened. Our findings call for the system-
atic screening of patients at the time of admission as
well as in communities to identify asymptomatic carriers
who act as disseminators, in order to find out true bur-
den of MDROs. There should be more targeted epidemi-
ologic and genotypic studies to provide insights on
MDRO acquisition and carriage in children.
Table 1 Descriptive statistics of study participants admitted in a tertiary care hospital (N = 347)
Variables n (%)
Age (years), Mean ± SD 6.7 ± 4.9
Gender Male 194 (55.9)
Unit of care Ward aSCU 3 (0.9)
General 251 (72.3)
Semiprivate 27 (7.8)
Private Wing 23 (6.6)
aPICU 43 (12.4)
Prior antibiotic use for > 48 h in the last 6 months 70 (20.2)
History of vaccination in the last 6 months 45 (13.0)
Prior health care facility exposure in the last 1 year 320 (92.2)
Past ICU stay > 72 h in the last 1 year 8 (2.3)
Prior use of medical devices at any time in the last 1 year 1 (0.3)
Stool culture positive for aMDRO 41/65 (63.1)
Rectal swab culture positive for aMDRO 181/257 (70.4)
Nasal swab culture positive for aMRSA 49/346 (14.2)
aMDRO carriers 237 (68.3)
aSCU Special Care Unit, PICU Pediatric Intensive Care Unit, MDRO Multi Drug Resistant Organism, MRSA Methicillin-Resistant Staphylococcus aureus
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Table 2 Descriptive characteristics of underlying diagnosis in children with MDRO colonization at the time of admission in a tertiary
care hospital (N = 347)
Diagnosis n (%)
Gastrointestinal Illnesses (n = 60)




Lower GI bleed 1 (1.7)
Respiratory illness and Allergies (n = 44)
Upper Respiratory Tract Infection 7 (15.9)
Bronchiolitis 3 (6.8)
Bronchopneumonia 14 (31.8)
Aspiration pneumonia 1 (2.3)
Acute Exacerbation of Asthma 14 (31.8)
Urticarial rash 5 (11.4)
Infectious Diseases (n = 169)
Cholera 1 (0.6)
Dysentery 6 (3.5)
Urinary Tract Infection 5 (3.0)
Viral Fever 3 (1.8)
Group C streptococcal sepsis 1 (0.6)
Herpetic gingivitis 1 (0.6)




Presumed Typhoid Fever 54 (50.5)
XDR Typhoid Fever 38 (35.5)
Typhoid fever 15 (14.0)
Acute Viral hepatitis 11 (6.5)
Invasive fungal sinusitis 1 (0.6)












cCardiovascular diseases (n = 6)
Neuropsychiatric diseases (n = 19)
Seizure disorder 2 (10.5)
Febrile fits 9 (47.3)
Syncope 2 (10.5)
Suspected Psychiatric illness 2 (10.5)
dOthers 4 (21.0)
Endocrine and Metabolic Diseases (n = 12)
Osteogenesis Imperfecta for zolendronate infusion 3 (25.0)
HMDPC Syndrome for EDTA chelation 3 (25.0)
eOthers 6 (50.0)
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Table 2 Descriptive characteristics of underlying diagnosis in children with MDRO colonization at the time of admission in a tertiary
care hospital (N = 347) (Continued)
Diagnosis n (%)
Autoimmune Disease (n = 7)
Celiac Disease 2 (28.5)
Suspected Inflammatory Bowel Disease 1 (14.3)
Autoimmune Vasculitis 1 (14.3)
Systemic lupus erythematosus (SLE) 2 (28.6)
Polyarthritis for workup 1 (14.3)
Trauma and Accidents (n = 4)
Concussion injury 1 (25.0)
History of Fall for observation 2 (50.0)
Drowning 1 (25.0)
Miscellaneous (n = 26)
Pancreatitis 3 (11.5)
Iron deficiency 2 (7.7)
Nephrotic syndrome 5 (19.2)
Nonspecific abdominal pain 2 (7.7)
fOthers 14 (53.8)
GI Gastrointestinal, XDR Extensively drug resistant, ASD Atrial Septal Defect, PDA Patent Ductus Arteriosus, HMDPC Hypermanganesemia with Dystonia,
Polycythemia and Cirrhosis, EDTA Ethylenediaminetetraacetic acid
aLiver abscess (MRSA: Methicillin-Resistant Staphylococcus aureus (1), amebic liver abscess (1)), Chin abscess (MRSA: Methicillin-Resistant Staphylococcus aureus), Chest
wall abscess (MRSA: Methicillin-Resistant Staphylococcus aureus)
bAbdominal Tuberculosis (1), Disseminated Tuberculosis (1), Left pyelitis (1), Post viral myalgia (1)
cASD repair (1), PDA device closure (2), Complex Congenital Heart Disease for Right heart catheterization (2), Postural hypotension (1)
dAcute Disseminated Encephalomyelitis (1), Migraine (1), Intraventricular Hemorrhage (1), Developmental delay for workup (1)
eInsulin Dependent Diabetes Mellitus (1), Hypoglycemia (1), hypocalcemic fits (1), Fructose 1,6 bisphosphatase Deficiency (1), Ketotic hypoglycemia (1), Maple Syrup
Disease with Leucine Toxicity (1)
fExcessive crying for observation (1), Scorpion bite (1), Spondylodiscitis (L4–5) (1), Muscular spasm (1), Inderal Overdose (1), Ultrasound guided liver biopsy (1), Impacted
ear wax (1), Obstructive jaundice (1), Chronic Liver Disease for band ligation (1), Posterior fossa mass (1), Suspected Zinc deficiency (1), Temporomandibular Joint
Disorder (1), Bleeding Disorder (1), Breath holding spells (1)
Fig. 2 Proportion of various microorganisms identified from positive stool/rectal swab culture (N = 222) (Uploaded as a separate PDF file)
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